Clinical Trial Highlights

Clinical Trial Highlights published on April 22, 2014
Dr. Volker Diehl discusses two important trials; a US trial for frontline therapy, ECHELON and a GHSG lead trial with escalated BEACOPP.
Clinical Trial Highlights published on March 24, 2014
Dr. Steidl discusses the significance of tumor-associated macrophages in classical Hodgkin lymphoma.
Clinical Trial Highlights published on February 18, 2014
Dr. Engert discusses the HD15 trial that explores the quality assurance protocol for reduction of toxicity and the prognostic relevance of FDG-PET in patients with advanced stage Hodgkin lymphoma.

Results 1 - 3 of 3

Managing HL would like to recognize and thank Merck & Co., Inc., Seattle Genetics, and Takeda Oncology for their educational support of ManagingHodgkinLymphoma.com

©2017 MediCom Worldwide, Inc. All rights reserved